Yesterday, Credit Suisse said without an industry recovery in volume or patient insurance, Tenet Healthcare (THC) might be required to file for Chapter 11 bankruptcy protection in three years. The company’s stock promptly dropped. The shares had been trading at $3.90 a few day ago, dropped ot $3.29. The shares were over $12 two years ago.
THC took exception to the report. This AM the company released a statement. "We believe we have the financial resources to execute our turnaround," said Biggs C. Porter, Tenet’s chief financial officer. Tenet had $675 million in cash at June 30, 2007 and had no outstanding borrowings on its line of credit which, under its terms, had $500 million in availability as of June 30, 2007. In addition, Tenet has no long-term debt maturing until December 2011.
While bad debt is rising and so is revenue from the uninsured, the company does expect adjusted EBITDA of $675 to $725 million this year.
Not great, but going bankrupt might be a little strong.
Shares opened up 4% at $3.48. The damage appears to have been done.
Douglas A. McIntyre
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
